Since LSD1, DNMT1, and VDR appear to have interconnected roles in PCa, we sought to identify an LSD1/DNMT1-centered genome-wide signature that has clinical relevance, measured as progression-free survival (PFS) and overall survival (OS). Here, DNMT1 is linked to posterior cortical atrophy.